http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2713403-T3
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_00cf135003c69ae281b696d3bc73e0c9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_43e0b7356fbc54935a76c8061c75b154 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D519-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-437 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-496 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P33-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D519-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-437 |
| filingDate | 2015-06-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2019-05-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_06ef6f9054c344535d336b782b498289 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dbbcffedad16e295318b960612d8a260 |
| publicationDate | 2019-05-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | ES-2713403-T3 |
| titleOfInvention | Pyrazolo-pyridine derivatives as kinase inhibitors |
| abstract | A compound of formula (IA), or a pharmaceutically acceptable salt or solvate thereof; ** Formula ** wherein Q represents a group of formula (Qa), (Qb), (Qc), (Qd) or (Qe) : ** Formula ** in which the asterisk (*) represents the point of attachment to the rest of the molecule; V represents -CH2-, -C (CH3) 2-, -CH2CH2- or -CH2CH2CH2-; W represents the residue of a C3-7 cycloalkyl group; Y represents -C (O) -, -C (O) N (R4) - or -C (O) C (O) -; Z represents aryl or heteroaryl, any of the groups may be optionally substituted with one, two or three substituents independently selected from halogen, cyano, nitro, C1-6 alkyl, trifluoromethyl, cyanoalkyl (C1-6), heterocycloalkyl (C3-7) , halo-heterocycloalkyl (C3-7), alkyl (C1-6) heterocycloalkyl (C3-7), alkoxycarbonyl (C2-6) heterocycloalkyl (C3-7), dihaloheterocycloalkyl (C3-7), heterocycloalkyl (C3-7) alkyl (C1-6), alkyl (C1-6) -heterocycloalkyl (C3-7) alkyl (C1-6), heteroaryl, hydroxy, oxo, C1-6 alkoxy, difluoromethoxy, trifluoromethoxy, trifluoroethoxy heterocycloalkoxy (C3-7), alkoxycarbonyl (C2-6) -heterocycloalkoxy (C3-7), heterocycloalkyl (C3-7) alkoxy (C1-6), aryloxy, haloaryloxy, alkoxyaryloxy (C1-6), C1-3 alkylenedioxy, dihaloalkylenedioxy (C1-3), arylcarbonyloxy , C 1-6 alkylthio, C 1-6 alkylsulfinyl, C 1-6 alkylsulfonyl, amino, C 1-6 alkylamino, C 1-6 dialkylamino, C 1-6 dialkylamino, C 1-6 alkyl, arylamino, C 2-6 alkylcarbonylamino, alkoxycar C2-6 bonylamino, C1-6 alkylsulfonylamino, formyl, C2-6 alkylcarbonyl, C3-6 cycloalkylcarbonyl, C3-6 heterocycloalkylcarbonyl, carboxy, C2-6 alkoxycarbonyl, aryloxycarbonyl, aminocarbonyl, C1-6 alkylaminocarbonyl, dialkylaminocarbonyl, alkylaminocarbonyl, alkylaminocarbonyl C1-6 alkylaminosulfonyl and (C1-6) dialkylaminosulfonyl; A1 represents C1-6 alkyl, optionally substituted with -ORa; A2 represents hydrogen or C1-6 alkyl; R represents hydrogen or C1-6 alkyl; R11 represents hydrogen or amino; R12 represents hydrogen, trifluoromethyl or C1-6 alkyl; R13 represents hydrogen or C1-6 alkyl; and Ra represents hydrogen or C1-6 alkyl. |
| priorityDate | 2014-06-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 266.